The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Sexually Transmitted Disease Testing Market Research Report 2025
Synopsis
Sexually Transmitted Disease (STD) testing is a medical procedure carried out to detect the presence of infections that are transmitted through sexual contact. STDs can be caused by bacteria, viruses, parasites, or fungi and can be asymptomatic or present symptoms such as genital sores, abnormal discharge, pain, itching, or burning sensation.Sexually Transmitted Disease Testing is used to find out if you have been infected with an STD. Testing can help you get the treatment you need and may help prevent the spread of disease.STD testing typically involves collecting samples like blood, urine, swabs from genital areas, or mouth/throat for laboratory analysis.
Global Sexually Transmitted Disease Testing market is projected to reach US$ 15220 million in 2029, increasing from US$ 9600 million in 2022, with the CAGR of 6.9% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Sexually Transmitted Disease Testing market research.
The global sexually transmitted disease (STD) testing market refers to the market for diagnostic tests used to identify and diagnose sexually transmitted infections. This includes tests for a wide range of STDs such as HIV, chlamydia, gonorrhea, syphilis, herpes, HPV (human papillomavirus), and others.
The STD testing market has experienced significant growth in recent years due to several factors, including:
Increasing prevalence of STDs: The global burden of STDs remains high, with millions of new infections reported every year. This has led to an increased demand for testing and diagnosis.
Growing awareness and education: Public awareness campaigns, initiatives by healthcare organizations, and educational programs have helped raise awareness about the importance of STD testing, leading to more individuals seeking testing services.
Technological advancements: Advances in diagnostic technologies have made it easier and faster to detect STDs. For instance, molecular testing methods such as Polymerase Chain Reaction (PCR) have improved the sensitivity and specificity of STD testing.
Expanding healthcare infrastructure: Improvements in healthcare infrastructure, especially in developing countries, have facilitated access to STD testing services.
The global STD testing market is characterized by the presence of several market players, including diagnostic laboratories, hospitals, and specialized testing centers. These entities offer a range of testing methods, from traditional laboratory-based tests to point-of-care testing kits.
The market is also influenced by government initiatives, policies, and regulations related to STD prevention and control. Additionally, the integration of STD testing services with other healthcare settings, such as primary care clinics and sexual health clinics, has contributed to the market’s growth.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Sexually Transmitted Disease Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Abbott Laboratories
Becton Dickinson and Company
Bio-Rad Laboratories
bioMerieux S.A.
Danaher Corporation
DiaSorin
Hologic
OraSure Technologies
Qiagen
Roche Holdings AG
Thermo Fisher Scientific
Segment by Type
Blood Testing
Urine Testing
Swab Testing
Segment by Application
Laboratory Testing
Point-of-Care (POC) Testing
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Sexually Transmitted Disease Testing report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Sexually Transmitted Disease (STD) testing is a medical procedure carried out to detect the presence of infections that are transmitted through sexual contact. STDs can be caused by bacteria, viruses, parasites, or fungi and can be asymptomatic or present symptoms such as genital sores, abnormal discharge, pain, itching, or burning sensation.Sexually Transmitted Disease Testing is used to find out if you have been infected with an STD. Testing can help you get the treatment you need and may help prevent the spread of disease.STD testing typically involves collecting samples like blood, urine, swabs from genital areas, or mouth/throat for laboratory analysis.
Global Sexually Transmitted Disease Testing market is projected to reach US$ 15220 million in 2029, increasing from US$ 9600 million in 2022, with the CAGR of 6.9% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Sexually Transmitted Disease Testing market research.
The global sexually transmitted disease (STD) testing market refers to the market for diagnostic tests used to identify and diagnose sexually transmitted infections. This includes tests for a wide range of STDs such as HIV, chlamydia, gonorrhea, syphilis, herpes, HPV (human papillomavirus), and others.
The STD testing market has experienced significant growth in recent years due to several factors, including:
Increasing prevalence of STDs: The global burden of STDs remains high, with millions of new infections reported every year. This has led to an increased demand for testing and diagnosis.
Growing awareness and education: Public awareness campaigns, initiatives by healthcare organizations, and educational programs have helped raise awareness about the importance of STD testing, leading to more individuals seeking testing services.
Technological advancements: Advances in diagnostic technologies have made it easier and faster to detect STDs. For instance, molecular testing methods such as Polymerase Chain Reaction (PCR) have improved the sensitivity and specificity of STD testing.
Expanding healthcare infrastructure: Improvements in healthcare infrastructure, especially in developing countries, have facilitated access to STD testing services.
The global STD testing market is characterized by the presence of several market players, including diagnostic laboratories, hospitals, and specialized testing centers. These entities offer a range of testing methods, from traditional laboratory-based tests to point-of-care testing kits.
The market is also influenced by government initiatives, policies, and regulations related to STD prevention and control. Additionally, the integration of STD testing services with other healthcare settings, such as primary care clinics and sexual health clinics, has contributed to the market’s growth.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Sexually Transmitted Disease Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Abbott Laboratories
Becton Dickinson and Company
Bio-Rad Laboratories
bioMerieux S.A.
Danaher Corporation
DiaSorin
Hologic
OraSure Technologies
Qiagen
Roche Holdings AG
Thermo Fisher Scientific
Segment by Type
Blood Testing
Urine Testing
Swab Testing
Segment by Application
Laboratory Testing
Point-of-Care (POC) Testing
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Sexually Transmitted Disease Testing report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sexually Transmitted Disease Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Blood Testing
1.2.3 Urine Testing
1.2.4 Swab Testing
1.3 Market by Application
1.3.1 Global Sexually Transmitted Disease Testing Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Laboratory Testing
1.3.3 Point-of-Care (POC) Testing
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sexually Transmitted Disease Testing Market Perspective (2018-2029)
2.2 Sexually Transmitted Disease Testing Growth Trends by Region
2.2.1 Global Sexually Transmitted Disease Testing Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Sexually Transmitted Disease Testing Historic Market Size by Region (2018-2023)
2.2.3 Sexually Transmitted Disease Testing Forecasted Market Size by Region (2024-2029)
2.3 Sexually Transmitted Disease Testing Market Dynamics
2.3.1 Sexually Transmitted Disease Testing Industry Trends
2.3.2 Sexually Transmitted Disease Testing Market Drivers
2.3.3 Sexually Transmitted Disease Testing Market Challenges
2.3.4 Sexually Transmitted Disease Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sexually Transmitted Disease Testing Players by Revenue
3.1.1 Global Top Sexually Transmitted Disease Testing Players by Revenue (2018-2023)
3.1.2 Global Sexually Transmitted Disease Testing Revenue Market Share by Players (2018-2023)
3.2 Global Sexually Transmitted Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Sexually Transmitted Disease Testing Revenue
3.4 Global Sexually Transmitted Disease Testing Market Concentration Ratio
3.4.1 Global Sexually Transmitted Disease Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sexually Transmitted Disease Testing Revenue in 2022
3.5 Sexually Transmitted Disease Testing Key Players Head office and Area Served
3.6 Key Players Sexually Transmitted Disease Testing Product Solution and Service
3.7 Date of Enter into Sexually Transmitted Disease Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Sexually Transmitted Disease Testing Breakdown Data by Type
4.1 Global Sexually Transmitted Disease Testing Historic Market Size by Type (2018-2023)
4.2 Global Sexually Transmitted Disease Testing Forecasted Market Size by Type (2024-2029)
5 Sexually Transmitted Disease Testing Breakdown Data by Application
5.1 Global Sexually Transmitted Disease Testing Historic Market Size by Application (2018-2023)
5.2 Global Sexually Transmitted Disease Testing Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Sexually Transmitted Disease Testing Market Size (2018-2029)
6.2 North America Sexually Transmitted Disease Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Sexually Transmitted Disease Testing Market Size by Country (2018-2023)
6.4 North America Sexually Transmitted Disease Testing Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sexually Transmitted Disease Testing Market Size (2018-2029)
7.2 Europe Sexually Transmitted Disease Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Sexually Transmitted Disease Testing Market Size by Country (2018-2023)
7.4 Europe Sexually Transmitted Disease Testing Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sexually Transmitted Disease Testing Market Size (2018-2029)
8.2 Asia-Pacific Sexually Transmitted Disease Testing Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Sexually Transmitted Disease Testing Market Size by Region (2018-2023)
8.4 Asia-Pacific Sexually Transmitted Disease Testing Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Sexually Transmitted Disease Testing Market Size (2018-2029)
9.2 Latin America Sexually Transmitted Disease Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Sexually Transmitted Disease Testing Market Size by Country (2018-2023)
9.4 Latin America Sexually Transmitted Disease Testing Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sexually Transmitted Disease Testing Market Size (2018-2029)
10.2 Middle East & Africa Sexually Transmitted Disease Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Sexually Transmitted Disease Testing Market Size by Country (2018-2023)
10.4 Middle East & Africa Sexually Transmitted Disease Testing Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Sexually Transmitted Disease Testing Introduction
11.1.4 Abbott Laboratories Revenue in Sexually Transmitted Disease Testing Business (2018-2023)
11.1.5 Abbott Laboratories Recent Development
11.2 Becton Dickinson and Company
11.2.1 Becton Dickinson and Company Company Detail
11.2.2 Becton Dickinson and Company Business Overview
11.2.3 Becton Dickinson and Company Sexually Transmitted Disease Testing Introduction
11.2.4 Becton Dickinson and Company Revenue in Sexually Transmitted Disease Testing Business (2018-2023)
11.2.5 Becton Dickinson and Company Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Detail
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories Sexually Transmitted Disease Testing Introduction
11.3.4 Bio-Rad Laboratories Revenue in Sexually Transmitted Disease Testing Business (2018-2023)
11.3.5 Bio-Rad Laboratories Recent Development
11.4 bioMerieux S.A.
11.4.1 bioMerieux S.A. Company Detail
11.4.2 bioMerieux S.A. Business Overview
11.4.3 bioMerieux S.A. Sexually Transmitted Disease Testing Introduction
11.4.4 bioMerieux S.A. Revenue in Sexually Transmitted Disease Testing Business (2018-2023)
11.4.5 bioMerieux S.A. Recent Development
11.5 Danaher Corporation
11.5.1 Danaher Corporation Company Detail
11.5.2 Danaher Corporation Business Overview
11.5.3 Danaher Corporation Sexually Transmitted Disease Testing Introduction
11.5.4 Danaher Corporation Revenue in Sexually Transmitted Disease Testing Business (2018-2023)
11.5.5 Danaher Corporation Recent Development
11.6 DiaSorin
11.6.1 DiaSorin Company Detail
11.6.2 DiaSorin Business Overview
11.6.3 DiaSorin Sexually Transmitted Disease Testing Introduction
11.6.4 DiaSorin Revenue in Sexually Transmitted Disease Testing Business (2018-2023)
11.6.5 DiaSorin Recent Development
11.7 Hologic
11.7.1 Hologic Company Detail
11.7.2 Hologic Business Overview
11.7.3 Hologic Sexually Transmitted Disease Testing Introduction
11.7.4 Hologic Revenue in Sexually Transmitted Disease Testing Business (2018-2023)
11.7.5 Hologic Recent Development
11.8 OraSure Technologies
11.8.1 OraSure Technologies Company Detail
11.8.2 OraSure Technologies Business Overview
11.8.3 OraSure Technologies Sexually Transmitted Disease Testing Introduction
11.8.4 OraSure Technologies Revenue in Sexually Transmitted Disease Testing Business (2018-2023)
11.8.5 OraSure Technologies Recent Development
11.9 Qiagen
11.9.1 Qiagen Company Detail
11.9.2 Qiagen Business Overview
11.9.3 Qiagen Sexually Transmitted Disease Testing Introduction
11.9.4 Qiagen Revenue in Sexually Transmitted Disease Testing Business (2018-2023)
11.9.5 Qiagen Recent Development
11.10 Roche Holdings AG
11.10.1 Roche Holdings AG Company Detail
11.10.2 Roche Holdings AG Business Overview
11.10.3 Roche Holdings AG Sexually Transmitted Disease Testing Introduction
11.10.4 Roche Holdings AG Revenue in Sexually Transmitted Disease Testing Business (2018-2023)
11.10.5 Roche Holdings AG Recent Development
11.11 Thermo Fisher Scientific
11.11.1 Thermo Fisher Scientific Company Detail
11.11.2 Thermo Fisher Scientific Business Overview
11.11.3 Thermo Fisher Scientific Sexually Transmitted Disease Testing Introduction
11.11.4 Thermo Fisher Scientific Revenue in Sexually Transmitted Disease Testing Business (2018-2023)
11.11.5 Thermo Fisher Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
